Move over, Mounjaro: New Eli Lilly drug lost patients 24 percent of their weight in trials ...Middle East

The Hill - News
Move over, Mounjaro: New Eli Lilly drug lost patients 24 percent of their weight in trials
A new Eli Lilly experimental drug has helped patients lose 24 percent of their weight, according to new mid-stage clinical trial results.  The results, released on Monday, followed 338 adults, nearly 52 percent of whom were men, who were obese or overweight and had either received Eli Lilly’s retatrutide injection or a placebo treatment.  Eli Lilly’s retatrutide is a weekly injection that changes the way patients eat, which leads to the paitent having a decreased appetite by mimicking certain hormones in the gut, according to CNBC.  Retatrutide is also comparable to Eli Lilly’s other obesity drug, Mounjaro.  Mounjaro, which can also be used for Type 2 diabetes treatment, helpe

Hence then, the article about move over mounjaro new eli lilly drug lost patients 24 percent of their weight in trials was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Move over, Mounjaro: New Eli Lilly drug lost patients 24 percent of their weight in trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News